TGF-β induces telomerase-dependent pancreatic tumor cell cycle arrest

Molecular and Cellular Endocrinology

Volumn 320, Issue 1-2, 2010, Pages 97-105

  Cassar, Lucy ^a   Li, He ^a   Jiang, Fang Xu ^b   Liu, Jun Ping ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cell cycle; Telomerase; TGF

Indexed keywords

CYTOKINE; SMAD3 PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE REPRESSION; IMMUNOFLUORESCENCE; NONHUMAN; PANCREAS CANCER; PLASMID; PRIORITY JOURNAL; RAT; RNA ISOLATION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; G1 PHASE; HUMANS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTEIN TRANSPORT; RATS; S PHASE; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA;

EID: 77949567180     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.002     Document Type: Article

References (78)

1. Ahmed S., Passos J.F., Birket M.J., Beckmann T., Brings S., Peters H., Birch-Machin M.A., von Zglinicki T., Saretzki G. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J. Cell Sci. 2008, 121:1046-1053.
2. Armstrong L., Saretzki G., Peters H., Wappler I., Evans J., Hole N., von Zglinicki T., Lako M. Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells 2005, 23:516-529.
3. Attisano L., Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 2002, 296:1646-1647.
4. Bayne S., Jones M.E., Li H., Pinto A.R., Simpson E.R., Liu J.P. Estrogen deficiency induces telomerase inhibition, telomere shortening and reduced cell proliferation in the adrenal gland of mice. Cell Res. 2008, 18:1141-1150.
5. Beliveau A., Yaswen P. Soothing the watchman: telomerase reduces the p53-dependent cellular stress response. Cell Cycle 2007, 6:1284-1287.
6. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.-P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
7. Bottinger E.P., Letterio J.J., Roberts A.B. Biology of TGF-[beta] in knockout and transgenic mouse models. Kidney Int. 1997, 51:1355-1360.
8. Brizzi M.F., Dentelli P., Rosso A., Calvi C., Gambino R., Cassader M., Salvidio G., Deferrari G., Camussi G., Pegoraro L., Pagano G., Cavallo-Perin P. RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy. FASEB J. 2004, 18:1249-1251.
9. Broccoli D., Young J.W., de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9082-9086.
10. Cao Y., Li H., Deb S., Liu J.P. TERT regulates cell survival independent telomerase activity. Oncogene 2002, 21:3130-3138.
11. Cassar L., Li H., Pinto A.R., Nicholls C., Bayne S., Liu J.-P. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. Cancer Res. 2008, 68:9157-9166.
12. Chebel A., Bauwens S., Gerland L.M., Belleville A., Urbanowicz I., de Climens A.R., Tourneur Y., Chien W.W., Catallo R., Salles G., Gilson E., Ffrench M. Telomere uncapping during in vitro T-lymphocyte senescence. Aging Cell 2009, 8:52-64.
13. Chick W.L., Warren S., Chute R.N., Like A.A., Lauris V., Kitchen K.C. A transplantable insulinoma in the rat. Proc. Natl. Acad. Sci. U.S.A. 1977, 74:628-632.
14. Choi J., Southworth L.K., Sarin K.Y., Venteicher A.S., Ma W., Chang W., Cheung P., Jun S., Artandi M.K., Shah N., Kim S.K., Artandi S.E. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet. 2008, 4:e10.
15. Crowe D.L., Nguyen D.C., Ohannessian A. Mechanism of telomerase repression during terminal differentiation of normal epithelial cells and squamous carcinoma lines. Int. J. Oncol. 2005, 27:847-854.
16. Darbro B.W., Lee K.M., Nguyen N.K., Domann F.E., Klingelhutz A.J. Methylation of the p16(INK4a) promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cells. Oncogene 2006, 25:7421-7433.
17. Deacu E., Mori Y., Sato F., Yin J., Olaru A., Sterian A., Xu Y., Wang S., Schulmann K., Berki A., Kan T., Abraham J.M., Meltzer S.J. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes. Cancer Res. 2004, 64:7690-7696.
18. Debacq-Chainiaux F., Borlon C., Pascal T., Royer V., Eliaers F., Ninane N., Carrard G., Friguet B., de Longueville F., Boffe S., Remacle J., Toussaint O. Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-beta1 signaling pathway. J. Cell Sci. 2005, 118:743-758.
19. Denchi E.L., de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007, 448:1068-1071.
20. Deng Y., Guo X., Ferguson D.O., Chang S. Multiple roles for MRE11 at uncapped telomeres. Nature 2009, 460:914-918.
21. Dhar S., Squire J.A., Hande M.P., Wellinger R.J., Pandita T.K. Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability. Mol. Cell Biol. 2000, 20:7764-7772.
22. Dong M., Blobe G.C. Role of transforming growth factor-beta in hematologic malignancies. Blood 2006, 107:4589-4596.
23. Eisenhauer K.M., Gerstein R.M., Chiu C.P., Conti M., Hsueh A.J. Telomerase activity in female and male rat germ cells undergoing meiosis and in early embryos. Biol. Reprod. 1997, 56:1120-1125.
24. Flores I., Cayuela M.L., Blasco M.A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 2005, 309:1253-1256.
25. Forsyth N.R., Wright W.E., Shay J.W. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 2002, 69:188-197.
26. Haendeler J., Drose S., Buchner N., Jakob S., Altschmied J., Goy C., Spyridopoulos I., Zeiher A.M., Brandt U., Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler. Thromb. Vasc. Biol. 2009, 29:929-935.
27. Han S.U., Kim H.T., Seong D.H., Kim Y.S., Park Y.S., Bang Y.J., Yang H.K., Kim S.J. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 2004, 23:1333-1341.
28. He H., Wang Y., Guo X., Ramchandani S., Ma J., Shen M.F., Garcia D.A., Deng Y., Multani A.S., You M.J., Chang S. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita. Mol. Cell Biol. 2009, 29:229-240.
29. Heldin C.H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390:465-471.
30. Hu B., Tack D.C., Liu T., Wu Z., Ullenbruch M.R., Phan S.H. Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFbeta. Oncogene 2006, 25:1030-1041.
31. Jady B.E., Richard P., Bertrand E., Kiss T. Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol. Biol. Cell 2006, 17:944-954.
32. Jagadeesh S., Banerjee P.P. Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem. Biophys. Res. Commun. 2006, 347:774-780.
33. Katakura Y., Nakata E., Miura T., Shirahata S. Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem. Biophys. Res. Commun. 1999, 255:110-115.
34. Kim S.H., Davalos A.R., Heo S.J., Rodier F., Zou Y., Beausejour C., Kaminker P., Yannone S.M., Campisi J. Telomere dysfunction and cell survival: roles for distinct TIN2-containing complexes. J. Cell Biol. 2008, 181:447-460.
35. Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., Klingelhutz A.J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998, 396:84-88. (see comments).
36. Kolquist K.A., Ellisen L.W., Counter C.M., Meyerson M., Tan L.K., Weinberg R.A., Haber D.A., Gerald W.L. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat. Genet. 1998, 19:182-186. (see comments).
37. Ksiazek K., Korybalska K., Jorres A., Witowski J. Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF-beta1. Lab. Invest. 2007, 87:345-356.
38. Kume S., Haneda M., Kanasaki K., Sugimoto T., Araki S., Isshiki K., Isono M., Uzu T., Guarente L., Kashiwagi A., Koya D. SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J. Biol. Chem. 2007, 282:151-158.
39. Kyo S., Takakura M., Kohama T., Inoue M. Telomerase activity in human endometrium. Cancer Res. 1997, 57:610-614.
40. Kyo S., Takakura M., Tanaka M., Kanaya T., Sagawa T., Kohama T., Ishikawa H., Nakano T., Shimoya K., Inoue M. Expression of telomerase activity in human chorion. Biochem. Biophys. Res. Commun. 1997, 241:498-503.
41. Lacerte A., Korah J., Roy M., Yang X.J., Lemay S., Lebrun J.J. Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal. 2008, 20:50-59.
42. Lamm N., Ordan E., Shponkin R., Richler C., Aker M., Tzfati Y. Diminished telomeric 3' overhangs are associated with telomere dysfunction in hoyeraal-hreidarsson syndrome. PLoS ONE 2009, 4:e5666.
43. Lavranos T.C., Mathis J.M., Latham S.E., Kalionis B., Shay J.W., Rodgers R.J. Evidence for ovarian granulosa stem cells: telomerase activity and localization of the telomerase ribonucleic acid component in bovine ovarian follicles. Biol. Reprod. 1999, 61:358-366.
44. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., Greider C.W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392:569-574.
45. Lee M.K., Hande M.P., Sabapathy K. Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. J. Cell Sci. 2005, 118:819-829.
46. Li H., Zhao L.L., Funder J.W., Liu J.P. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. 1997, 272:16729-16732.
47. Li H., Pinto A.R., Duan W., Li J., Toh B.H., Liu J.P. Telomerase down-regulation does not mediate PC12 pheochromocytoma cell differentiation induced by NGF, but requires MAP kinase signalling. J. Neurochem. 2005, 95:891-901.
48. Li H., Xu D., Li J., Berndt M.C., Liu J.P. Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene. J. Biol. Chem. 2006, 281:25588-25600.
49. Li B., Smith C.C., Laing J.M., Gober M.D., Liu L., Aurelian L. Overload of the heat-shock protein H11/HspB8 triggers melanoma cell apoptosis through activation of transforming growth factor-beta-activated kinase 1. Oncogene 2007, 26:3521-3531.
50. Liu T., Hu B., Chung M.J., Ullenbruch M., Jin H., Phan S.H. Telomerase regulation of myofibroblast differentiation. Am. J. Respir. Cell Mol. Biol. 2006.
51. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev. 2005, 19:2783-2810.
52. Massagué J., Blain S.W., Lo R.S. TGF[beta] signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
53. Masutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A., Weinberg R.A., Stewart S.A., Hahn W.C. Telomerase maintains telomere structure in normal human cells. Cell 2003, 114:241-253.
54. Morrison S.J., Prowse K.R., Ho P., Weissman I.L. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996, 5:207-216.
55. Murofushi Y., Nagano S., Kamizono J., Takahashi T., Fujiwara H., Komiya S., Matsuishi T., Kosai K. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy. Int. J. Oncol. 2006, 29:681-688.
56. Pardali K., Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 2007, 1775:21-62.
57. Poh M., Boyer M., Solan A., Dahl S.L., Pedrotty D., Banik S.S., McKee J.A., Klinger R.Y., Counter C.M., Niklason L.E. Blood vessels engineered from human cells. Lancet 2005, 365:2122-2124.
58. Rajaraman S., Choi J., Cheung P., Beaudry V., Moore H., Artandi S.E. Telomere uncapping in progenitor cells with critical telomere shortening is coupled to S-phase progression in vivo. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17747-17752.
59. Roberts A.B., Sporn M.B. The transforming growth factor-betas. Peptide Growth Factors and their Receptors 1991, 419-472. Springer-Verlag, Heidelberg. M.B. Sporn, A.B. Roberts (Eds.).
60. Sarin K.Y., Cheung P., Gilison D., Lee E., Tennen R.I., Wang E., Artandi M.K., Oro A.E., Artandi S.E. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005, 436:1048-1052.
61. Sebestyen A., Hajdu M., Kis L., Barna G., Kopper L. Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells. Exp. Cell Res. 2007, 313:3167-3174.
62. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
63. Smith C.D., Blackburn E.H. Uncapping and deregulation of telomeres lead to detrimental cellular consequences in yeast. J. Cell Biol. 1999, 145:203-214. (in process citation).
64. Ten Hagen K.G., Gilbert D.M., Willard H.F., Cohen S.N. Replication timing of DNA sequences associated with human centromeres and telomeres. Mol. Cell Biol. 1990, 10:6348-6355.
65. Tomlinson R.L., Ziegler T.D., Supakorndej T., Terns R.M., Terns M.P. Cell cycle-regulated trafficking of human telomerase to telomeres. Mol. Biol. Cell 2006, 17:955-965.
66. Urbanek K., Torella D., Sheikh F., De Angelis A., Nurzynska D., Silvestri F., Beltrami C.A., Bussani R., Beltrami A.P., Quaini F., Bolli R., Leri A., Kajstura J., Anversa P. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8692-8697.
67. Vijayachandra K., Lee J., Glick A.B. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res. 2003, 63:3447-3452.
68. Wada T., Pippin J.W., Terada Y., Shankland S.J. The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis. Kidney Int. 2005, 68:1618-1629.
69. Wang J., Hannon G.J., Beach D.H. Risky immortalization by telomerase. Nature 2000, 405:755-756. (in process citation).
70. Wang J., Feng H., Huang X.Q., Xiang H., Mao Y.W., Liu J.P., Yan Q., Liu W.B., Liu Y., Deng M., Gong L., Sun S., Luo C., Liu S.J., Zhang X.J., Li D.W. Human telomerase reverse transcriptase immortalizes bovine lens epithelial cells and suppresses differentiation through regulation of the ERK signaling pathway. J. Biol. Chem. 2005, 280:22776-22787.
71. Wang J., Yang L., Yang J., Kuropatwinski K., Wang W., Liu X.Q., Hauser J., Brattain M.G. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Cancer Res. 2008, 68:3152-3160.
72. Wright W.E., Tesmer V.M., Liao M.L., Shay J.W. Normal human telomeres are not late replicating. Exp. Cell Res. 1999, 251:492-499.
73. Xu D., Dwyer J., Li H., Duan W., Liu J.P. Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. J. Biol. Chem. 2008, 283:23567-23580.
74. Yang Y., Pan X., Lei W., Wang J., Shi J., Li F., Song J. Regulation of transforming growth factor-beta 1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3. Cancer Res. 2006, 66:8617-8624.
75. Yang C., Przyborski S., Cooke M.J., Zhang X., Stewart R., Anyfantis G., Atkinson S.P., Saretzki G., Armstrong L., Lako M. A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells 2008, 26:850-863.
76. Yue J., Mulder K.M. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol. Ther. 2001, 91:1-34.
77. Zhao Y.M., Li J.Y., Lan J.P., Lai X.Y., Luo Y., Sun J., Yu J., Zhu Y.Y., Zeng F.F., Zhou Q., Huang H. Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2008, 369:1114-1119.
78. Zhu X.L., Kumar R., Mandal M., Sharma N., Sharma H.W., Dhingra U., Sokoloski J.A., Hsiao R.S., Narayanan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:6091-6095.